Skip to main content

Table 2 Primary and upgaze intraocular pressure change from baseline to completion of the study

From: Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series

Baseline primary IOP

14.89

± 1.501799332

Baseline lateral IOP

15.75

± 2.336307628

Baseline upgaze IOP

21.0

± 3.962497809

Final primary IOP

12.61

± 1.393879921

Final lateral IOP

14.72

± 1.859866914

Final upgaze IOP

15.22

± 1.808757844

Mean drop in IOP primary

−2.28

 

Mean drop in IOP lateral

−1.03

 

Mean drop in IOP upgaze

−5.78

 

% decrease primary

15.31

 

% decrease lateral

6.54

 

% decrease upgaze

22.52

 

p value primary

0.0397

 

p value lateral

0.6394

 

p value upgaze

0.1481

 
  1. IOP, intraocular pressure